Cita APA (7a ed.)
X, P., Y, L., Y, Q., Q, T., B, Q., L, Y., . . . G, Z. (2010). Efficacy and tolerability of first-line triple therapy with levofloxacin and amoxicillin plus esomeprazole or rabeprazole for the eradication of Helicobacter pylori infection and the effect of CYP2C19 genotype: A 1-week, randomized, open-label study .. Clinical Therapeutics, 32(12), 2003-2012.
Cita Chicago Style (17a ed.)
X, Pan, Li Y, Qiu Y, Tang Q, Qian B, Yao L, Shi R, y Zhang G. "Efficacy and Tolerability of First-line Triple Therapy with Levofloxacin and Amoxicillin Plus Esomeprazole or Rabeprazole for the Eradication of Helicobacter Pylori Infection and the Effect of CYP2C19 Genotype: A 1-week, Randomized, Open-label Study .." Clinical Therapeutics 32, no. 12 (2010): 2003-2012.
Cita MLA (9a ed.)
X, Pan, et al. "Efficacy and Tolerability of First-line Triple Therapy with Levofloxacin and Amoxicillin Plus Esomeprazole or Rabeprazole for the Eradication of Helicobacter Pylori Infection and the Effect of CYP2C19 Genotype: A 1-week, Randomized, Open-label Study .." Clinical Therapeutics, vol. 32, no. 12, 2010, pp. 2003-2012.
Precaución: Estas citas no son 100% exactas.